Trip or No Trip? The Diverging Development of Psychedelic Drugs for Mental Health (Subscription required) Adrienne Rivlin Read more
Executive Insights Life Sciences & Pharma L.E.K. Consulting’s Look at Key Trends in Pharma Services for 2023 March 2, 2023
Executive Insights Biotech and Pharmaceuticals Shareholder Value Creation for First-Time Launchers: Two Decades of Learnings December 30, 2022
Article Life Sciences & Pharma How Clinical Development in China Is Shifting Its Focus to High-Quality Growth November 11, 2022